Sohei Harada
Impact in
- Molecular Medicine top 0.5%
- Antibiotic Resistance in Bacteria
- Endocrinology top 2%
- Enterobacteriaceae and Cronobacter Research
Papers in
-
- Antibiotic Resistance in Bacteria 28
-
- Antimicrobial Resistance in Staphylococcus 12
- COVID-19 Clinical Research Studies 11
- Amoebic Infections and Treatments 7
- Co-authors
- Yoshikazu Ishii (15 shared papers)Kazuhiro Tateda (18 shared papers)Yohei Doi (13 shared papers)Tomoo Saga (9 shared papers)Keizo Yamaguchi (6 shared papers)Kotaro Aoki (15 shared papers)Koh Okamoto (31 shared papers)Kyoji Moriya (24 shared papers)
- Journals
- Journal of Clinical Microbiology (6 papers)Microbiology Spectrum (5 papers)International Journal of Infectious Diseases (5 papers)Antimicrobial Agents and Chemotherapy (4 papers)BMC Infectious Diseases (4 papers)
- Partner nations
- JapanUnited StatesIreland
In The Last Decade
Sohei Harada
80 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 107
- Molecular Medicine 591
- Endocrinology 217
- Applied Microbiology and Biotechnology 55
- Infectious Diseases 369
- Clinical Biochemistry 106
Countries citing papers authored by Sohei Harada
This map shows the geographic impact of Sohei Harada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sohei Harada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sohei Harada more than expected).
Fields of papers citing papers by Sohei Harada
This network shows the impact of papers produced by Sohei Harada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sohei Harada. The network helps show where Sohei Harada may publish in the future.
Co-authors
The 25 scholars most cited alongside Sohei Harada, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 91 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 102 | |
| 2 | 2019 | 89 | |
| 3 | 2018 | 75 | |
| 4 | 2012 | 63 | |
| 5 | 2018 | 61 | |
| 6 | 2012 | 59 | |
| 7 | 2010 | 53 | |
| 8 | 2011 | 40 | |
| 9 | 2011 | 36 | |
| 10 | 2011 | 36 | |
| 11 | 2008 | 35 | |
| 12 | 2021 | 33 | |
| 13 | 2018 | 32 | |
| 14 | 2012 | 26 | |
| 15 | 2015 | 24 | |
| 16 | 2014 | 24 | |
| 17 | 1987 | 24 | |
| 18 | 2013 | 23 | |
| 19 | 2012 | 23 | |
| 20 | 2022 | 23 |
About Sohei Harada
Sohei Harada is a scholar working on Molecular Medicine, Infectious Diseases, Endocrinology, Epidemiology and Clinical Biochemistry, having authored 91 papers that have together received 1.3k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (28 papers), Antimicrobial Resistance in Staphylococcus (12 papers), COVID-19 Clinical Research Studies (11 papers), Mycobacterium research and diagnosis (11 papers), Bacterial Identification and Susceptibility Testing (10 papers), Infective Endocarditis Diagnosis and Management (9 papers), Amoebic Infections and Treatments (7 papers) and Enterobacteriaceae and Cronobacter Research (5 papers). The work is most often cited by research in Molecular Medicine (591 citations), Endocrinology (217 citations), Applied Microbiology and Biotechnology (55 citations), Infectious Diseases (369 citations) and Clinical Biochemistry (106 citations). Sohei Harada has collaborated with scholars based in Japan, United States and Ireland. Frequent co-authors include Yoshikazu Ishii, Kazuhiro Tateda, Yohei Doi, Tomoo Saga, Keizo Yamaguchi, Kotaro Aoki, Koh Okamoto, Kyoji Moriya, Yoshikazu Ishii and Toru Kamiya. Their work appears in journals such as Journal of Clinical Microbiology, Microbiology Spectrum, International Journal of Infectious Diseases, Antimicrobial Agents and Chemotherapy and BMC Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.